D.C. RIJKEN

630 total citations
8 papers, 455 citations indexed

About

D.C. RIJKEN is a scholar working on Hematology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, D.C. RIJKEN has authored 8 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in D.C. RIJKEN's work include Blood Coagulation and Thrombosis Mechanisms (5 papers), Protease and Inhibitor Mechanisms (4 papers) and Blood properties and coagulation (3 papers). D.C. RIJKEN is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (5 papers), Protease and Inhibitor Mechanisms (4 papers) and Blood properties and coagulation (3 papers). D.C. RIJKEN collaborates with scholars based in Netherlands and Belgium. D.C. RIJKEN's co-authors include H.R. Lijnen, Frank W.G. Leebeek, Niels Bovenschen, Koen Mertens, Bart J.M. van Vlijmen, Louis M. Havekes, R M Bertina, Ana H.C. Guimarães, M.J. Schalij and Edmund Nobel and has published in prestigious journals such as Thrombosis and Haemostasis, Journal of Thrombosis and Haemostasis and Seminars in Thrombosis and Hemostasis.

In The Last Decade

D.C. RIJKEN

8 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.C. RIJKEN Netherlands 6 223 101 84 84 62 8 455
Zuzana Kolková Slovakia 14 60 0.3× 98 1.0× 140 1.7× 106 1.3× 30 0.5× 29 452
T. Mather United States 8 546 2.4× 66 0.7× 106 1.3× 65 0.8× 185 3.0× 10 790
Hema Kothari United States 15 212 1.0× 30 0.3× 119 1.4× 95 1.1× 100 1.6× 30 590
Lina Paola D’Atri Argentina 13 226 1.0× 54 0.5× 226 2.7× 63 0.8× 46 0.7× 16 753
Rinku Majumder United States 17 339 1.5× 29 0.3× 121 1.4× 87 1.0× 23 0.4× 40 610
Roy Schrijver Netherlands 8 85 0.4× 42 0.4× 139 1.7× 46 0.5× 89 1.4× 10 482
Knut Anders Mosevoll Norway 13 159 0.7× 35 0.3× 122 1.5× 31 0.4× 86 1.4× 25 456
TC Wun United States 6 566 2.5× 82 0.8× 66 0.8× 112 1.3× 178 2.9× 9 785
Lisa M. Regan United States 12 729 3.3× 37 0.4× 83 1.0× 73 0.9× 100 1.6× 16 887
Sjoukje H. Slofstra Netherlands 10 155 0.7× 21 0.2× 85 1.0× 44 0.5× 81 1.3× 11 350

Countries citing papers authored by D.C. RIJKEN

Since Specialization
Citations

This map shows the geographic impact of D.C. RIJKEN's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.C. RIJKEN with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.C. RIJKEN more than expected).

Fields of papers citing papers by D.C. RIJKEN

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.C. RIJKEN. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.C. RIJKEN. The network helps show where D.C. RIJKEN may publish in the future.

Co-authorship network of co-authors of D.C. RIJKEN

This figure shows the co-authorship network connecting the top 25 collaborators of D.C. RIJKEN. A scholar is included among the top collaborators of D.C. RIJKEN based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.C. RIJKEN. D.C. RIJKEN is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
RIJKEN, D.C. & Frank W.G. Leebeek. (2015). The Fibrinolytic Status in Liver Diseases. Seminars in Thrombosis and Hemostasis. 41(5). 474–480. 52 indexed citations
2.
Wee, Eva M. de, Jeroen Eikenboom, Johanna G. van der Bom, et al.. (2011). Effect of fibrinolysis on bleeding phenotype in moderate and severe. Data Archiving and Networked Services (DANS). 9. 200–200. 1 indexed citations
3.
RIJKEN, D.C., Edmund Nobel, A.F.H. Jie, et al.. (2008). Development of a new test for the global fibrinolytic capacity in whole blood. Journal of Thrombosis and Haemostasis. 6(1). 151–157. 23 indexed citations
4.
RIJKEN, D.C. & H.R. Lijnen. (2008). New insights into the molecular mechanisms of the fibrinolytic system. Journal of Thrombosis and Haemostasis. 7(1). 4–13. 261 indexed citations
5.
Guimarães, Ana Paula de Campos, Marrie Barrett-Bergshoeff, Marco Criscuoli, Stefano Evangelista, & D.C. RIJKEN. (2006). Fibrinolytic efficacy of Amediplase, Tenecteplase and scu-PA in different external plasma clot lysis models. Thrombosis and Haemostasis. 96(9). 325–330. 9 indexed citations
6.
RIJKEN, D.C., et al.. (2006). ID: 256 Evidence for an enhanced fibrinolytic capacity in cirrhosis measured with a new global fibrinolysis test in whole blood.. Journal of Thrombosis and Haemostasis. 4(s1). 222–222. 1 indexed citations
7.
Guimarães, Ana H.C., R M Bertina, & D.C. RIJKEN. (2005). A new functional assay of thrombin activatable fibrinolysis inhibitor. Journal of Thrombosis and Haemostasis. 3(6). 1284–1292. 18 indexed citations
8.
Bovenschen, Niels, D.C. RIJKEN, Louis M. Havekes, Bart J.M. van Vlijmen, & Koen Mertens. (2005). The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor. Journal of Thrombosis and Haemostasis. 3(6). 1257–1265. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026